ストックスクリーナーアプリを入手
0.4194
0.33%
0.0014
アフターアワーズ：
.42
0.0006
+0.14%
前日終値:
$0.418
開ける：
$0.4
24時間の取引高:
332.07K
Relative Volume:
0.09
時価総額：
$4.71M
収益：
$11.79M
当期純損益:
$-41.04M
株価収益率:
-0.0123
EPS:
-33.9843
ネットキャッシュフロー:
$-26.29M
1週間 パフォーマンス:
-16.62%
1か月 パフォーマンス:
-24.25%
6か月 パフォーマンス:
-75.20%
1年 パフォーマンス:
-92.59%
1日の値動き範囲:
$0.3986
$0.4264
1週間の範囲:
$0.3986
$0.5418
52週間の値動き範囲:
$0.3986
$14.07
Jaguar Health Inc Stock (JAGX) Company Profile
名前
Jaguar Health Inc
セクター
電話
415-371-8300
住所
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Compare JAGX vs VRTX, REGN, ALNY, ARGX, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
JAGX
Jaguar Health Inc
|
0.4194 | 4.71M | 11.79M | -41.04M | -26.29M | -33.98 |
VRTX
Vertex Pharmaceuticals Inc
|
454.00 | 115.33B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
732.87 | 77.48B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
312.17 | 41.40B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
663.93 | 41.09B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
275.28 | 30.56B | 5.36B | 287.73M | 924.18M | 2.5229 |
Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-07-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-07-11 | 開始されました | Rodman & Renshaw | Buy |
Jaguar Health Inc (JAGX) 最新ニュース
Will Jaguar Health Inc outperform the market in YEAR2026 Risk Factors & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Should value investors consider Jaguar Health Inc2026 Dividend Review & AI Based Trade Execution Alerts - baoquankhu1.vn
JAGX Forecast, Price Target & Analyst Ratings | JAGUAR HEALTH INC (NASDAQ:JAGX) - ChartMill
Jaguar Health (JAGX) Advances Pediatric Crofelemer Study - GuruFocus
FDA Feedback Supports Extension Phase for Jaguar Health's Clinical Trial of Crofelemer for Treatment of Microvillus Inclusion Disease (MVID) - Yahoo! Finance Canada
Published on: 2026-03-19 06:11:46 - baoquankhu1.vn
Earnings Recap: Is Jaguar Health Inc stock a top performer YTDDay Trade & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates - Seacoastonline.com
Jaguar Health unit begins coca extract study for weight management By Investing.com - Investing.com South Africa
Jaguar Health (JAGX) Launches Preclinical Study on Coca Leaf Ext - GuruFocus
Jaguar Health unit begins coca extract study for weight management - Investing.com
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression - ACCESS Newswire
Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression - FinanzNachrichten.de
Can coca leaves help keep weight off after GLP-1 drugs end? - Stock Titan
Jaguar Health, Inc. Trade Ideas — GETTEX:1JA0 - TradingView
Performance Recap: Will Jaguar Health Inc benefit from AI trends2026 Rallies & Real-Time Buy Zone Alerts - baoquankhu1.vn
Jaguar Health (NASDAQ: JAGX) asks shareholders to OK reverse splits, large potential dilution - Stock Titan
JAGX Stock Price, Quote & Chart | JAGUAR HEALTH INC (NASDAQ:JAGX) - ChartMill
Jaguar Health at Life Sciences Forum: Strategic Shift to Rare Diseases - Investing.com
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Sheboygan Press
Director John Micek granted stock options and RSUs at Jaguar Health (JAGX) - Stock Titan
Jaguar Health Presenting March 12 at the Life Sciences Virtual Investor Forum to Provide Updates on Near-Term Catalysts - Bradenton Herald
User - The Chronicle-Journal
Published on: 2026-03-11 18:03:23 - baoquankhu1.vn
Jaguar Health (JAGX) Restructures Debt and Reduces Royalties - GuruFocus
Jaguar Health, Inc. Enters Global Amendment Agreements and Security Agreement – March 2026 8-K Filing Details - Minichart
According to the latest SEC filing, Jaguar Health Inc (NASDAQ: JAGX) has completed the amendment to the Uptown 2020 royalty interest agreement. - Bitget
Jaguar Animal Health Restructures Debt and Royalty Agreements - TipRanks
Jaguar Health Strengthens Company's Balance Sheet by Restructuring and Reducing Royalty and Debt Obligations and Extinguishing Warrants - ACCESS Newswire
Jaguar Health Extends Debt, Defers Royalty Payments; Terminates 48,211-Share Warrants - TradingView
Debt extensions and warrant termination reshape Jaguar Health (NASDAQ: JAGX) - Stock Titan
Jaguar Health trims $3M in debt and royalties, extends loans to July 2026 - Stock Titan
Jaguar Health executes strategic stock exchange agreements - MSN
Jaguar Health Secures an Additional $3 Million Payment from Future Pak for Mytesi and Canalevia-CA1 - ACCESS Newswire
JAGXJaguar Health Announces a Special One-time Stock Dividend - mx.advfn.com
Jaguar Health receives Nasdaq delisting notice after share price falls below $1 - Investing.com
Revenue Check: Is Jaguar Health Inc gaining market shareJuly 2025 Weekly Recap & Weekly Stock Breakout Alerts - baoquankhu1.vn
Jaguar Health Faces Nasdaq Delisting, Plans to Appeal - TipRanks
Jaguar Health Received Notice of Delisting - TradingView
Jaguar Health (NASDAQ: JAGX) confronts Nasdaq delisting risk after bid-price breach - Stock Titan
Jaguar Animal Health Declares Special Series O Dividend - The Globe and Mail
Jaguar Health receives $3M from Future Pak licensing deal By Investing.com - Investing.com India
Jaguar Health receives $3M from Future Pak licensing deal - Investing.com South Africa
Jaguar Animal Health Issues Racing Data Summary for Horses Participating in the Company’s Recently Completed Dose Determina... - mx.advfn.com
Jaguar Animal Health and Henry Schein, Inc. Sign Exclusive Distribution Agreement for Neonorm Foal - Revista ADVFN
Jaguar Health announces Series O preferred stock dividend and new certificate of designation - Investing.com Nigeria
Jaguar Health (JAGX) Secures $3M Payment From Future Pak - GuruFocus
[8-K] Jaguar Health, Inc. Reports Material Event | JAGX SEC FilingForm 8-K - Stock Titan
Jaguar Health adds $3M as it targets crofelemer for rare intestinal failure - Stock Titan
JAGX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Jaguar Health, Inc.Common Stock (NQ: JAGX - The Chronicle-Journal
Jaguar Health Inc (JAGX) 財務データ
収益
当期純利益
現金流量
EPS
0.37%
大文字化:
|
ボリューム (24 時間):